Stratec H1 Sales Down 11.9%

Stratec (SBSG), on Wednesday, reported H1 sales of EUR 137.2 million, down 11.9% compared to EUR 155.8 million last year.

Reduction in sales was largely due to the high volume of pandemic-related additional demand for molecular diagnostic laboratory capacities in the previous year.

Earnings for the quarter totaled EUR 1.04 per share compared to EUR 2.08 per share earned a year ago.

Adjusted net income was EUR 16.7 million or EUR 1.38 per share versus EUR 28.5 million or EUR 2.36 per share in the prior year period.

Looking ahead, Stratec confirmed its financial guidance for the 2022 financial year. On a constant-currency basis, sales are still expected to match the previous year's figure. The adjusted EBIT margin is still forecast without amendment at around 16.5% - 18.5%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration said it now intends to review only a small subset of new emergency use authorization or EUA requests for diagnostic tests. As per an updated COVID-19 test policy with a view to ensure continued access to tests, the regulator further urged developers of all test types seeking marketing authorization to pursue traditional premarket review for most test types. Netflix, Inc. said it is adding a new feature to offer a more personalized mobile games experience on the platform. In a statement, Sophia Yang, Product Manager, Mobile Games, said the company is rolling out the ability to create game handles, with which members will be able to create a unique public username. This can be used across all Netflix games. General Motors Co. has delayed its plan to require employees to return to office many days a week until next year, reports said citing an internal memo signed by CEO Mary Barra. Last week, the company had announced that corporate workers would be required to return to respective offices at least three days a week, beginning later this year, as the COVID-19 pandemic eases.
Follow RTT